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Abstract 32 
 33 
Prion diseases are characterized by a conformational change in the normal host protein 34 
PrPC. While the majority of mature PrPC is tethered to the plasma membrane by a 35 
glycosylphosphatidyl-inositol anchor, topological variants of this protein can arise during its 36 
biosynthesis. Here we have generated Drosophila transgenic for cytosolic ovine PrP in order 37 
to investigate its toxic potential in the fly in the absence and presence of exogenous ovine 38 
prions. While cytosolic ovine PrP expressed in Drosophila was predominantly detergent 39 
insoluble and showed resistance to low concentrations of Proteinase K, it was not overtly 40 
detrimental to the fly. However, Drosophila transgenic for cytosolic PrP expression exposed 41 
to classical or atypical scrapie prion inocula showed an accelerated decrease in locomotor 42 
activity compared to similar flies exposed to scrapie-free material. The susceptibility to 43 
classical scrapie inocula could be assessed in Drosophila transgenic for pan neuronal 44 
expression of cytosolic PrP whereas susceptibility to atypical scrapie required ubiquitous PrP 45 
expression. Significantly, the toxic phenotype induced by ovine scrapie in cytosolic PrP 46 
transgenic Drosophila was transmissible to recipient PrP transgenic flies. These data show 47 
that while cytosolic PrP expression does not adversely affect Drosophila, this topological PrP 48 
variant can participate in the generation of transmissible scrapie-induced toxicity. These 49 
observations also show that PrP transgenic Drosophila are susceptible to classical and 50 
atypical scrapie prion strains and highlight the utility of this invertebrate host to model 51 
mammalian prion disease. 52 
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Importance  54 
 55 
During prion diseases, the host protein PrPC converts into an abnormal conformer PrPSc, a 56 
process coupled to the generation of transmissible prions and neurotoxicity. While PrPC is 57 
principally a glycosylphosphatidyl-inositol-anchored membrane protein, the role of topological 58 
variants, such as cytosolic PrP, in prion-mediated toxicity and prion formation is undefined. 59 
Here we have generated Drosophila transgenic for cytosolic PrP expression in order to 60 
investigate its toxic potential in the absence and presence of exogenous prions. Cytosolic 61 
ovine PrP expressed in Drosophila was not overtly detrimental to the fly. However, cytosolic 62 
PrP transgenic Drosophila exposed to ovine scrapie showed a toxic phenotype absent in 63 
similar flies exposed to scrapie-free material. Significantly, the scrapie-induced toxic 64 
phenotype in cytosolic transgenic Drosophila was transmissible to recipient PrP transgenic 65 
flies. These data show that cytosolic PrP can participate in the generation of transmissible 66 
prion-induced toxicity and highlight the utility of Drosophila to model mammalian prion 67 
disease.  68 
 69 
 70 
 71 
 72 
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Introduction 73 
 74 
Prion diseases, or transmissible spongiform encephalopathies (TSEs) are fatal 75 
neurodegenerative disorders of humans and various other mammalian species (1). These 76 
conditions include scrapie of sheep, Bovine Spongiform Encephalopathy (BSE) of cattle, 77 
Creutzfeldt–Jakob disease (CJD) of humans and Chronic Wasting Disease (CWD) of cervids. 78 
Susceptibility to prion disease requires expression of the host-encoded protein PrPC (2-5). 79 
Furthermore, prion diseases are associated with conversion of PrPC, the normal form of the 80 
prion protein, into an abnormal conformer PrPSc in a template-directed manner (6, 7). 81 
Misfolding of PrP is associated with an increase in β-sheet content of the protein, which 82 
accumulates principally in the central nervous system of affected individuals. There is now 83 
considerable evidence to suggest that the transmissible prion agent comprises PrPSc (8-14). 84 
However, despite intensive investigation, the molecular mechanisms of PrPC to PrPSc 85 
conversion and of prion-mediated neurodegeneration remain unknown.  86 
 87 
Although PrPC is highly conserved amongst different mammalian species its physiological 88 
functions remain elusive. PrPC is a glycosylphosphatidyl-inositol (GPI)-anchored 89 
sialoglycoprotein, principally located in lipid rafts on the outer leaf of the cell membrane (15, 90 
16). Nascent PrPC is synthesized as a pre-protein of approximately 250 amino acid residues 91 
in length. The N-terminal leader peptide is cleaved as PrP enters the endoplasmic reticulum 92 
(ER) and the C-terminal signal sequence is cleaved upon attachment of the GPI anchor that 93 
holds the protein to the membrane (15, 17, 18). Inside the ER lumen PrPC undergoes 94 
additional post translational modification with the addition of carbohydrate structures at two 95 
asparagine residues (19). In addition, a di-sulfide bond forms within the C-terminal globular 96 
domain (20). During its biosynthesis, PrP may undergo aberrant translocation since leader 97 
peptide inefficiency prevents all of the nascent protein entering into the lumen of the ER. As a 98 
consequence, subpopulations of PrP are either retained fully in the cytosol (PrPcyt) or 99 
produced as a membrane-bound protein with either N- or C-terminal residues exposed to the 100 
cytosol (21-24). ER misfolded and aberrantly translocated proteins are targeted for 101 
degradation by the ubiquitin proteasome system (UPS), the major cellular proteolytic 102 
pathway, or via the autophagic / lysosomal system. While normal levels of cytosolic and 103 
aberrantly translocated PrP are usually metabolized by the cell, these forms of PrP have 104 
been reported to be neurotoxic when present in elevated amounts (25-28). Increased cellular 105 
levels of cytosolic PrP may arise as a consequence of PrPSc-mediated inhibition of the 106 
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catalytic activity of the proteasome in cells (29-31). The role of cytosolic PrP in the generation 107 
of infectious prions has yet to be determined.  108 
 109 
Ovine scrapie is an important model of prion disease, not only for the natural host but for 110 
mammalian species in general (32, 33). Polymorphisms within ovine PrPC correlate with 111 
susceptibility to different types of scrapie in sheep. Four major polymorphisms in the ovine 112 
prion protein, located at amino acid residues 136, 141, 154 and 171 are associated, in some 113 
cases relatively (34, 35), with susceptibility to two classifications of scrapie disease (36-38). 114 
Sheep that express A136L141R154Q171 (termed ARQ, where A, L, R and Q stand for alanine, 115 
leucine, arginine and glutamine, respectively) or V136L141R154Q171 (termed VRQ, where V 116 
stands for valine) ovine PrP are susceptible to classical scrapie, a transmissible prion 117 
disease within the natural host (39). In contrast, a different ovine prion disease, referred to as 118 
atypical or Nor98 scrapie, has been reported in classical scrapie-resistant PrP genotypes 119 
including A136L141R154R171 (termed ARR), A136F141R154Q171 (termed AFRQ, where F stands for 120 
phenylalanine) and A136L141H154Q171 (termed AHQ, where H stands for histidine) (38). It is 121 
considered that atypical scrapie is a spontaneous disorder of PrP folding and/or metabolism 122 
(38, 40), although transmission by the oral route cannot yet be excluded (41-44). We have 123 
begun to model sheep scrapie in Drosophila in order to develop a more tractable model of 124 
mammalian prion disease. In doing so, we have previously generated Drosophila transgenic 125 
for polymorphic variants of ovine PrP expressed with a GPI anchor sequence [PrP(GPI)] 126 
(45). Furthermore, we have shown that Drosophila transgenic for AHQ(GPI) ovine PrP show 127 
a significant reduction in median survival time compared to flies transgenic for VRQ(GPI). It 128 
has yet to be established whether the toxic potential of AHQ prion protein is mediated by a 129 
cytosolic variant of this particular genotype of ovine PrP and whether cytosolic PrP per se 130 
can participate in prion-mediated toxicity.   131 
 132 
Here we have generated Drosophila transgenic for polymorphic variants of cytosolic ovine 133 
PrP in order to investigate for the first time its toxic potential in the fly in the absence and 134 
presence of exogenous ovine prions. While cytosolic ovine PrP expressed pan neuronally in 135 
Drosophila was predominantly detergent insoluble and showed protease resistance to low 136 
concentrations of Proteinase K (PK), it was not overtly detrimental to the fly. In contrast, 137 
Drosophila transgenic for cytosolic PrP expression exposed to classical or atypical scrapie 138 
prion inocula showed an accelerated decrease in locomotor activity compared to similar flies 139 
exposed to scrapie-free material. The susceptibility to classical ovine scrapie was evident in 140 
Drosophila transgenic for pan neuronal cytosolic PrP whereas susceptibility to atypical ovine 141 
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scrapie required ubiquitous expression. Significantly, the toxic phenotype induced by ovine 142 
scrapie in cytosolic transgenic Drosophila was transmissible to PrP transgenic recipient flies. 143 
These data show that while cytosolic ovine PrP is not inherently neurotoxic in Drosophila, 144 
this topological variant can participate in the generation of a transmissible toxicity induced by 145 
scrapie prion inocula. These novel observations highlight the utility of Drosophila to model 146 
mammalian prion disease.  147 
 148 
149 
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Materials and Methods 149 
 150 
Fly stocks and generation of cytosolic ovine PrP transgenic Drosophila 151 
The UAS-PrP(GPI) fly lines w; M{AHQ-PrP(GPI), 3xP3-RFP.attP}ZH-51D and w; M{ARQ-152 
PrP(GPI), 3xP3-RFP.attP}ZH-51D, that are transgenic for ovine A136H154Q171 or A136R154Q171 153 
PrP, respectively, expressed with an N-terminal leader peptide and C-terminal 154 
glycosylphosphatidyl-inositol (GPI) signal sequence [AHQ(GPI) and ARQ(GPI), respectively]  155 
were generated by PhiC31 site-specific transformation as previously described (45). The 156 
UAS-PrP(cyt) fly lines generated here were w; M{AHQ-PrP, 3xP3-RFP.attP}ZH-51D, w; 157 
M{ARQ-PrP, 3xP3-RFP.attP}ZH-51D, and w; M{VRQ-PrP, 3xP3-RFP.attP}ZH-51D. The 158 
ovine PrP(cyt) transgenes for insertion into the Drosophila genome were prepared by PCR 159 
that generated a DNA fragment encoding ovine PrP amino acid residues 25-232. PCR was 160 
carried out in the presence of Pfu DNA polymerase (Promega) using substrate plasmid DNA 161 
that contained an insert encoding AHQ, ARQ or VRQ ovine PrP amino acid residues 25-252 162 
(45) and oligonucleotide primers P2 (forward primer): 5ʼ GATGA GAA TTC AAC ATG AAG 163 
AAG CGA CCA AAA CCT GGC 3ʼ; and P4 (reverse primer):  5ʼ ACGATGAA CTC GAG CTA 164 
CCC CCT TTG GTA ATA AG 3ʼ. The PCR primers P2 and P4 contained EcoR1 and Xho1 165 
restriction sites, respectively, that allowed directional cloning of the 658bp PCR product into 166 
the Drosophila transgenesis vector pUASTattB. A Kozak translation site (46) was 167 
incorporated into the forward primer and a stop codon was incorporated into the reverse 168 
primer ahead of the Xho1 restriction site. The PCR reaction conditions comprised an initial 169 
denaturation at 95 °C for 2 minutes followed by 30 cycles of denaturation at 95 °C for 30 170 
seconds, primer annealing at 55 °C for 30 seconds and primer extension at 75 °C for 1 171 
minute, and a final extension of the PCR product at 75 °C for 10 minutes. PCR products that 172 
contained DNA encoding PrP(cyt) DNA were subsequently ligated into pUASTattB and 173 
rescued by transformation in DH5α bacteria. Plasmid DNA was isolated from transformed 174 
bacteria by an alkaline lysis method using the Qiagen maxiprep kit and the PrP construct 175 
insert verified by DNA sequence analysis. Site-specific transformation of the pUASTattB-PrP 176 
constructs into the 51D fly line (y[1] M{vas-int.Dm}ZH-2A w[*]; M{3xP3-RFP.attP}ZH-51D) 177 
was performed by Bestgene Inc (California, USA). F1 flies were balanced and viable lines 178 
were maintained as balanced stocks by conventional fly crosses. DNA sequence analysis 179 
was performed on genomic DNA from each balanced fly line to confirm the presence of the 180 
correct PrP transgene at the 51D site. Cre-mediated removal of RFP from the fly genome of 181 
VRQ(cyt) PrP was performed by conventional fly crosses. Elav-GAL4 182 
(P{w[+mW.hs]=GawB}elav[C155]) and GMR-GAL4 (w; wg[Sp-1]/CyO; GMR-GAL4, 183 
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w+/TM6B) driver lines, and the control 51D (w; M{3xP3-RFP.attP}ZH-51D) fly line were 184 
obtained from the Department of Genetics, University of Cambridge, UK. All fly lines were 185 
raised on standard cornmeal media (47) at 25 °C and maintained at low to medium density. 186 
Flies were used in the assays described below or harvested at various time points and then 187 
frozen at -80 ˚C until required. 188 
 189 
Prion inoculation of Drosophila       190 
Primary passage of sheep scrapie (sheep-to-fly): Drosophila at the larval stage of 191 
development were exposed to brain homogenates from confirmed scrapie-positive or known 192 
scrapie-negative sheep. The classical scrapie-infected isolates were prepared from terminal 193 
scrapie-affected sheep identified by routine statutory surveillance (VRQ/VRQ isolate 194 
SE1848/0005; ARQ/ARQ isolate SE1848/0008) (50). The atypical scrapie-infected isolates 195 
(n=2) were prepared from terminal AHQ/AHQ sheep challenged intracerebrally with atypical 196 
scrapie and that were confirmed positive for the disease (43). New Zealand-derived 197 
VRQ/VRQ (n=1), ARQ/ARQ (n=1) or AHQ/AHQ (n=2) scrapie-free brain tissue was used as 198 
control material. Two hundred and fifty microlitres of a 1 % brain homogenate prepared in 199 
PBS pH 7.4 were added to the top of the cornmeal that contained third instar Drosophila 200 
larvae in 3” plastic vials. Flies were transferred to fresh, non-treated vials following eclosion.  201 
Secondary passage of sheep scrapie (fly-to-fly): Drosophila brain homogenates were 202 
prepared from 30 day old flies that had been exposed at the larval stage to scrapie-positive 203 
or scrapie-negative sheep brain material. Two hundred and fifty microlitres of a 10 % dilution 204 
(v/v) of the original fly brain homogenate were added to the top of the cornmeal that 205 
contained third instar Drosophila larvae in 3” plastic vials. Flies were transferred to fresh, 206 
non-treated vials following eclosion. 207 
 208 
Preparation of fly head homogenates  209 
Whole flies in an eppendorf tube were frozen in liquid nitrogen for 10 minutes followed by 2 210 
minutes of vortexing. Individual fly heads were then isolated and placed in clean eppendorf 211 
tubes using a paint brush. Homogenates were prepared by manual grinding of fly heads in 212 
eppendorf tubes with sterilized plastic pestles. Homogenates for ELISA or western blot 213 
without Proteinase K (PK) digestion of PrP were prepared by processing 20 fly heads in 20 µl 214 
of lysis buffer [50 mM Tris pH 7.5, 100 mM NaCl, 0.5 % (v/v) Nonidet P-40 and 1 mM 4-(2-215 
Aminoethyl) benzenesulfonyl fluoride (AEBSF)]. In the case of PK digestion of PrP, AEBSF 216 
was not added to the lysis buffer. Homogenates for conformational-dependent immunoassay 217 
(CDI) were prepared by processing 40 fly heads in 8 µl of 8M GdnHCl, incubated at 18 ˚C for 218 
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15 minutes followed by a 1:50 dilution in assay buffer and assessed as described previously 219 
(48). Homogenates for fly-to-fly transmission (secondary passage samples) were prepared 220 
by processing 150 male and 150 female fly heads per group previously harvested at 30 days 221 
of age. Each group of 300 fly heads was added to 300 µl of PBS (pH 7.4) prior to 222 
homogenization. 223 
 224 
Preparation of soluble and insoluble prion protein fractions 225 
PrP fractions were prepared from fly head homogenates using a method adapted from 226 
Fernandez-Funez et al. (49). A volume of fly head homogenate that was equivalent to 20 fly 227 
heads was mixed with 20 µl of 10 % (w/v) Sarkosyl pH 7.4. The sample was shaken at 225 228 
rpm for 10 minutes at 37 °C, 5 units of Benzonase were added and the sample was shaken 229 
at 225 rpm for a further 10 minutes at 37 °C. Sodium phosphotungstic acid (diluted in PBS 230 
pH 7.4) was added to the reaction mix to give 0.3 % w/v final concentration and the tubes 231 
were shaken at 225 rpm for 30 minutes at 37 °C prior to centrifugation at 16,000 X g for 30 232 
minutes at 4 °C. To obtain the soluble and insoluble PrP fractions, the supernatant (soluble 233 
fraction, 40 µl) was transferred to a fresh tube and the pellet (insoluble fraction) was 234 
resuspended in 40 µl of 0.1 % w/v Sarkosyl in PBS pH 7.4.  235 
 236 
Proteinase K digestion of fly head homogenate 237 
Fly head homogenates were prepared in 1.5 ml eppendorf tubes by processing 10 fly heads 238 
in 9 µl of lysis buffer (50 mM Tris pH 7.5, 100 mM NaCl, 0.5 % Nonidet P-40) using plastic 239 
pestles. A 1 µl volume of PK at x10 the required concentration was added to the homogenate 240 
and the mixture incubated at 37 ºC for 15 minutes. Proteolysis was stopped by the addition of 241 
1.1 µl of 10 mM AEBSF and the samples analyzed by SDS-PAGE and western blot to detect 242 
PrP.   243 
 244 
SDS-PAGE and western blot 245 
Fly head homogenate was mixed with an equal volume of x2-strength Laemmli loading 246 
buffer, boiled for 10 minutes, cooled on ice and then centrifuged at 13,000 X g for 5 minutes 247 
at 18 °C to remove debris. Fly head homogenate was subjected to SDS/PAGE run under 248 
reducing conditions and western blot as described in detail previously (50) except that the 249 
nitrocellulose membranes were probed with a 1:2000 dilution of anti-PrP monoclonal 250 
antibody Sha31 (51).  251 
 252 
Capture-detector ELISA  253 
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Duplicate 40 µl aliquots of fly head homogenate were diluted to 100 µl with PBS pH 7.4. PrP 254 
was quantified by capture-detector ELISA carried out as described previously (52) except 255 
that the capture reagent was anti-PrP monoclonal antibody 245 (53) and the detector 256 
antibody was biotinylated SAF32 (51). The equivalent of 10 fly heads were assayed per well 257 
in duplicate.  258 
 259 
Conformational-dependent immunoassay (CDI)  260 
Head homogenate was prepared as described above and PrP was quantified by CDI as 261 
described previously (48) except that the capture reagent was anti-PrP monoclonal antibody 262 
245 (53) and the detector antibody was biotinylated SAF32 (51). The equivalent of 20 fly 263 
heads were assayed per well in duplicate. 264 
 265 
Survival assay 266 
Newly eclosed flies were allowed to mature and mate for 24 hours before the females were 267 
separated and collected for survival assays. One hundred flies of each genotype were 268 
housed in groups of 10 and the flies were flipped every 2 to 3 days onto fresh food. The 269 
number of dead flies was recorded three times a week (45). Survival curves were calculated 270 
using Kaplan-Meier plots and differences between them were analyzed by the log-rank 271 
method using Prism (GraphPad Software Inc, San Diego, USA).  272 
 273 
Locomotor assay  274 
The locomotor ability of flies was assessed in a negative geotaxis climbing assay as 275 
described previously (54). Briefly, age-matched, pre-mated female flies were placed in 276 
adapted plastic 25 ml pipettes that were used as vertical climbing columns. The flies were 277 
allowed to acclimatize for 30 minutes prior to assessment of their locomotor ability.  Flies 278 
were tapped to the bottom of the pipette (using the same number and intensity of taps) and 279 
then allowed to climb for 45 seconds. At the end of the climbing period the number of flies 280 
above the 25 ml mark, the number below the 2 ml mark and the number in between the 2 ml 281 
and 25 ml mark were recorded. This procedure was performed three times at each time 282 
point. The mean performance index (PI) ± SD for each group of flies was calculated as 283 
described (54).  284 
  285 
Statistical analysis 286 
 11 
Statistical analysis of the data was performed by one-way analysis of variance, together with 287 
Tukey highly significant difference (HSD) for post hoc analysis or the unpaired samples t test 288 
using Prism (GraphPad Software Inc, San Diego, USA)  . 289 
 290 
 291 
292 
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Results 292 
 293 
Cytosolic ovine PrP expression in Drosophila 294 
Here we have generated Drosophila transgenic for polymorphic variants of cytosolic ovine 295 
PrP in order to investigate the toxic potential of intracellular PrP expression in the absence or 296 
presence of exogenous prions. The data in Figure 1 show the western blot detection of 297 
cytosolic PrP [PrP(cyt)] expression in Drosophila. The analysis in Figure 1a shows that 298 
ARQ(cyt), AHQ(cyt) and VRQ(cyt) were all efficiently expressed at a similar level pan 299 
neuronally in the fly. The molecular mass of all three genotypes of PrP(cyt) was 300 
approximately 27kDa, the same as that of non-glycosylated ovine recombinant PrP. The 301 
analysis in Figure 1b shows that AHQ(cyt) and VRQ(cyt) transgenic Drosophila expressed 302 
significantly higher levels of PrP compared to flies that expressed AHQ or VRQ PrP with a 303 
GPI anchor sequence [PrP(GPI)]. The opposite trend was seen with Drosophila that 304 
expressed the ARQ PrP genotype.  305 
 306 
 We subsequently used capture-detector ELISA with C-terminal-specific anti-PrP monoclonal 307 
antibodies in order to quantify the level of each genotype of cytosolic ovine PrP expressed in 308 
Drosophila. The data in Figure 2a show that significantly lower levels of pan neuronally 309 
expressed ovine PrP(cyt) were recognized by the anti-PrP-specific ELISA compared to ovine 310 
PrP(GPI). This observation suggested that cytosolic ovine PrP may adopt a distinct 311 
conformation compared to other forms of ovine PrP expressed in Drosophila that are 312 
recognized by this ELISA (45). In order to test this, we used a conformational-dependent 313 
immunoassay (CDI) whereby PrP(cyt) was denatured by guanidine prior to its recognition by 314 
capture-detector immunoassay (48). The data in Figure 2b show that all of the genotypes of 315 
cytosolic ovine PrP expressed pan neuronally in Drosophila were recognized by the 316 
denaturant-based CDI.  317 
 318 
Cytosolic PrP is predominantly detergent insoluble and displays protease resistance 319 
We next investigated whether the immunobiochemical properties of PrP(cyt) expressed in 320 
Drosophila correlated with distinct conformers of the ovine prion protein. Figure 3 shows a 321 
comparison of ARQ(cyt) and ARQ(GPI) with respect to detergent solubility and relative 322 
resistance to proteolytic digest. In order to determine the detergent solubility of cytosolic 323 
ovine PrP we extracted fly head homogenates with Sarkosyl to prepare soluble and insoluble 324 
fractions for subsequent analysis by western blot with anti-PrP monoclonal antibody Sha31. 325 
The data in Figure 3a show that while Elav-driven ARQ(cyt) and ARQ(GPI) flies both 326 
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displayed a major band of approximately 27kDa in detergent soluble and insoluble head 327 
homogenate fractions, the proportion of PrP present in these fractions varied. The level of 328 
insoluble prion protein was greater than the level of soluble material in Elav-ARQ(cyt) flies 329 
compared to that of the Elav-ARQ(GPI) fly line. The data in Figure 3b show the western blot 330 
analysis of PK-digested fly head homogenate from pan neuronal ARQ(cyt) and ARQ(GPI) 331 
flies. Pan neuronally expressed ARQ(GPI) PrP was readily cleaved by PK when treated with 332 
3 - 9 µg/ml of proteolytic enzyme. In contrast, ARQ(cyt) was resistant to digestion with PK 333 
when treated with the proteolytic enzyme used in the same concentration range and was only 334 
susceptible to complete digest when PK was used in excess of 27 µg/ml. All three 335 
polymorphic variants of cytosolic ovine PrP showed these trends (data not shown).   336 
 337 
Survival of cytosolic ovine PrP transgenic Drosophila 338 
Cytosolic PrP accumulation is toxic to some neurons (26, 55) and may be part of the 339 
neurotoxic mechanism associated with prion diseases (25). It was important therefore to 340 
determine the effect of cytosolic PrP expression on the general well being of Drosophila prior 341 
to prion infectivity studies in these fly lines.  342 
 343 
The data in Figure 4 show the survival curves for PrP transgenic fly lines that pan neuronally 344 
expressed cytosolic ovine prion protein in comparison with the survival curve for the control 345 
Elav-51D fly line. Cytosolic PrP expression did not appear to be overtly detrimental to 346 
Drosophila since the survival curve for each of the ovine PrP transgenic fly lines showed a 347 
similar profile to that of the non-transgenic 51D control flies. However, log-rank test analysis 348 
showed that the survival curves of all three genotypes of prion protein transgenic fly lines 349 
were significantly different to that of the 51D control flies (p≤0.002) and this was reflected in 350 
differences in median survival times, which were: 51D 86 days; AHQ(cyt) 81 days; ARQ(cyt) 351 
79 days; and VRQ(cyt) 76 days. The general lack of toxicity in Drosophila as a consequence 352 
of pan neuronal cytosolic PrP expression was also evident when PrP(cyt) was expressed 353 
ubiquitously. For example, the percent survival for β-actin-driven and elav-driven VRQ(cyt) 354 
PrP transgenic flies was similar at approximately 90 % and 95 %, respectively, when 355 
assessed at 50 days of age. 356 
 357 
Cytosolic PrP transgenic Drosophila are susceptible to ovine prion inocula 358 
In order to assess whether cytosolic ovine PrP transgenic Drosophila were susceptible to the 359 
toxic effect of exogenous ovine prion inocula, flies at the larval stage of development were 360 
exposed to scrapie-infected sheep brain material and the locomotor activity of prion-exposed 361 
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flies assessed after eclosion (i.e. hatching). The prion inoculum used here was sheep brain 362 
homogenate derived from natural cases of VRQ/VRQ and ARQ/ARQ classical (50) or 363 
AHQ/AHQ experimental atypical (43) sheep scrapie. Genotype matched scrapie-free brain 364 
homogenates were used as control material and 51D Drosophila were used as the control fly 365 
line, which were similarly exposed to scrapie-infected and scrapie-free sheep brain 366 
homogenate. 367 
 368 
In order to assess the response to classical scrapie prion inocula, β-actin- or Elav-driven 369 
VRQ(cyt) Drosophila were exposed at the larval stage to VRQ/VRQ scrapie-infected sheep 370 
brain homogenate. Figure 5 shows the climbing ability expressed as a performance index of 371 
prion exposed and control flies post-eclosion. The data in Figure 5a show that prion-exposed 372 
β-actin-driven VRQ(cyt) Drosophila displayed a significantly accelerated decline in locomotor 373 
activity compared to similar flies exposed to genotype-matched control brain homogenate 374 
(p<0.001 over the whole assay). In contrast, β-actin-driven 51D flies showed a similar decline 375 
in locomotor activity following exposure to scrapie-infected or genotype matched control 376 
sheep brain homogenate. The data in Figure 5b show that prion-exposed Elav-driven 377 
VRQ(cyt) Drosophila also showed a significantly accelerated decline in locomotor activity 378 
compared to similar flies exposed to genotype-matched control brain homogenate (p<0.05 379 
between days 2 and 51 of the assay), which was somewhat reduced compared to that seen 380 
by β-actin-driven VRQ(cyt) Drosophila. In contrast, the performance index of elav-driven 381 
VRQ(cyt) PrP transgenic Drosophila exposed to ARQ/ARQ scrapie-infected sheep brain 382 
homogenate was not significantly different to that of similar flies exposed to scrapie-free 383 
ARQ/ARQ sheep brain homogenate (data not shown). Elav-driven 51D flies showed no 384 
difference in the decline of locomotor activity following exposure to scrapie-infected or 385 
genotype matched control sheep brain homogenate.   386 
 387 
We subjected head homogenates from prion-exposed flies to proteolytic digest followed by 388 
western blot with anti-PrP monoclonal antibody in order to attempt to detect PK-resistant 389 
PrPSc. The data in Figure 6 show that the majority of pan neuronally expressed VRQ(cyt) 390 
from prion-exposed and control treated flies was digested with PK at 10 - 30 µg/ml and with 391 
similar resultant molecular profiles. At 20 days of age a greater fraction of the VRQ(cyt) was 392 
resistant to PK digestion at these concentrations of the proteolytic enzyme.  393 
 394 
We subsequently investigated whether the toxic phenotype displayed by prion-exposed 395 
VRQ(cyt) Drosophila was transmissible. In order to do so, we prepared homogenates from 396 
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the heads of 30 day-old Drosophila that had been exposed at the larval stage to either 397 
VRQ/VRQ prion-infected or genotype-matched scrapie-free sheep brain homogenate. Fly 398 
head homogenates were subsequently used to inoculate fresh batches of recipient VRQ(cyt) 399 
Drosophila larvae. After hatching, the locomotor activity of fly head homogenate-exposed 400 
Drosophila was assessed by a negative geotaxis climbing assay. The data in Figure 7 show 401 
that head homogenate from prion-exposed VRQ(cyt) Drosophila induced a significantly 402 
accelerated decline in locomotor activity compared to control fly head homogenates in 403 
VRQ(cyt) recipient flies (p<0.01 over the whole assay) (Figure 7a). In contrast, no significant 404 
differences were seen in the locomotor response of recipient VRQ(cyt) Drosophila to head 405 
homogenate prepared from non-transgenic 51D flies previously exposed to either scrapie-406 
infected or scrapie-free sheep brain material (Figure 7b).  407 
 408 
In order to assess the response to atypical scrapie prion inocula, β-Actin- or Elav-driven 409 
cytosolic AHQ(cyt) ovine PrP transgenic Drosophila were exposed at the larval stage to 410 
AHQ/AHQ prion-infected or genotype-matched scrapie-free sheep brain homogenate. β-411 
Actin- and Elav-driven AHQ(GPI) and Elav-driven ARQ(GPI) Drosophila, that both express 412 
PrP with a GPI anchor sequence, were included for comparison. The data in Figure 8 show 413 
the climbing ability of Drosophila with ubiquitous AHQ expression after exposure to atypical 414 
scrapie-infected sheep brain homogenate. β-Actin-driven AHQ(cyt) flies showed an 415 
accelerated decline in locomotor activity following exposure to atypical scrapie-infected 416 
sheep brain homogenate compared to control brain homogenate (p=0.0226 between day 8 417 
and day 39) (Figure 8a). Similarly, atypical prion-exposed β-Actin-driven AHQ(GPI) flies 418 
showed a significantly enhanced decline in locomotor activity compared to similar flies 419 
exposed to control inocula (P=0.0278 over the whole assay) (Figure 8b). β-Actin-driven 420 
ARQ(GPI) flies also showed a significantly enhanced decline in locomotor activity following 421 
exposure to AHQ/AHQ scrapie-infected brain homogenate compared to control inocula 422 
(p=0.0351 between day 8 and day 39) (Figure 8c). In contrast, β-Actin -driven 51D flies 423 
showed the same decline in locomotor activity following exposure to AHQ/AHQ scrapie-424 
infected or genotype-matched scrapie-free sheep brain homogenate (Figure 8d). Similar 425 
trends were seen with both atypical scrapie inocula (data not shown).  426 
 427 
Elav-driven AHQ(cyt), AHQ(GPI) or 51D flies showed no difference in decline of locomotor 428 
activity following exposure to AHQ/AHQ scrapie-infected brain homogenate compared to 429 
control brain homogenate. The data in Figure 9 show the climbing ability of Drosophila after 430 
exposure to atypical scrapie-infected and control sheep brain homogenate. Elav-driven 431 
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AHQ(cyt) flies showed a similar decline in locomotor activity following exposure to AHQ/AHQ 432 
scrapie-infected or genotype-matched scrapie-free sheep brain homogenate, or PBS (Figure 433 
9a). In a similar manner, Elav-driven AHQ(GPI) flies showed no difference in decline of 434 
locomotor activity following exposure to AHQ/AHQ scrapie-infected brain homogenate 435 
compared to control inocula (Figure 9b) although a response was seen at day 33 with one 436 
atypical scrapie inoculum (data not shown). In contrast to these data, Elav-driven ARQ(GPI) 437 
flies showed a significantly enhanced decline in locomotor activity following exposure to 438 
AHQ/AHQ scrapie-infected brain homogenate compared to control inocula (p<0.05 between 439 
day 7 and day 40) (Figure 9c). Elav-driven 51D flies showed the same decline in locomotor 440 
activity following exposure to AHQ/AHQ scrapie-infected sheep brain homogenate or control 441 
inocula (Figure 9d). Similar trends were seen with both atypical scrapie inocula (data not 442 
shown).  443 
 444 
445 
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Discussion 445 
 446 
The pathogenesis that occurs during prion diseases is associated with the conformational 447 
change of PrPC into PrPSc and concomitant neurodegeneration (1). However, the 448 
mechanism of PrP conversion and its role in neurotoxicity are unknown. While PrPC is 449 
primarily attached by a GPI anchor to the external side of the cell membrane, topological 450 
variants of the protein can arise during its biogenesis and metabolism (25). Here we have 451 
shown that one such variant, namely cytosolic PrP, can participate in the generation of a 452 
transmissible toxicity induced by ovine prion inocula.  453 
 454 
To do so, we have generated Drosophila that express cytosolic AHQ, ARQ or VRQ ovine 455 
PrP. All three cytosolic PrP variants were expressed at a similar level in the fly and 456 
comprised predominantly detergent insoluble material that showed resistance to proteolytic 457 
digest with relatively low concentrations of Proteinase K enzyme. In addition, epitopes 458 
normally exposed in ovine PrPC were either hidden or buried in PrP(cyt) since the latter 459 
required denaturation prior to its immunodetection by capture-detector immunoassay. The 460 
molecular profile and conformational properties of the PrP(cyt) variants expressed in 461 
Drosophila are distinct from those of the same polymorphic variants expressed with a GPI 462 
anchor in this host (45). This is likely to be due to the lack of post translational modifications 463 
experienced by PrP(cyt) as a consequence of its failure to enter the ER during biosynthesis. 464 
The modifications that PrPC normally experiences during its biogenesis include glycosylation 465 
and the introduction of a disulfide bond to the polypeptide chain, both of which influence 466 
protein folding and thermodynamic stability. Despite the acquisition of properties of misfolded 467 
prion protein, the pan neuronal expression of PrP(cyt) in Drosophila was not overtly 468 
detrimental to the fly. We have previously shown that Drosophila transgenic for AHQ 469 
expressed with a GPI anchor sequence displayed a median life-span that was significantly 470 
reduced compared to control 51D flies (45). Ovine AHQ PrP is associated with susceptibility 471 
to atypical scrapie in sheep, which is considered to be a spontaneous disorder of PrP folding 472 
and/or metabolism (38, 40) rather than an acquired condition (41-43). Our observation here 473 
that cytosolic AHQ does not induce a comparable toxicity to AHQ(GPI) suggests that the 474 
toxicity associated with AHQ targeted to the cell membrane is a consequence of this protein 475 
trafficking through the secretory pathway of the cell. The expression of AHQ variants of ovine 476 
PrP in Drosophila provides a novel model system to investigate the potential spontaneous 477 
misfolding of this genotype of ovine prion protein.  478 
 479 
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We assessed the response of PrP(cyt) transgenic Drosophila to exogenous ovine prions in a 480 
negative geotaxis climbing assay, a versatile and robust method used to assess locomotor 481 
defects in fly models of mammalian neurodegenerative conditions (54). Drosophila 482 
transgenic for VRQ(cyt) or AHQ(cyt) expression showed a decreased climbing ability after 483 
exposure at the larval stage to classical or atypical scrapie-infected sheep brain 484 
homogenate, respectively. The toxic effect of classical and atypical scrapie in PrP(cyt) 485 
transgenic Drosophila is suggestive of a prion-mediated effect as it was not induced by 486 
exposure to normal sheep brain homogenate and it was PrP dependent, since scrapie-487 
infected sheep brain homogenate was not toxic to non transgenic 51D flies. Importantly, we 488 
have shown that the toxic phenotype of prion-exposed PrP(cyt) flies was transmissible. Fly 489 
head homogenate from prion-exposed VRQ(cyt) PrP transgenic Drosophila  efficiently 490 
induced a toxic phenotype in recipient flies of the same genotype. This was not due to carry 491 
over of scrapie-infected sheep brain inocula in fly head homogenate since no effect was 492 
induced in recipient PrP(cyt) flies by prion-exposed non-transgenic 51D fly head inocula. 493 
These observations are suggestive of the generation of an infectious moiety, analogous to 494 
prion replication, during primary passage of scrapie in VRQ(cyt) flies (i.e. sheep-to-fly 495 
transmission) that was subsequently transmitted at secondary passage (i.e. fly-to-fly 496 
transmission). However, we were unable to demonstrate an increase in PK-resistant 497 
VRQ(cyt) PrP in prion exposed flies of this genotype. In other studies we have shown that 498 
protein misfolding cyclic amplification can be used to detect PK-resistant PrPSc in prion 499 
exposed VRQ(GPI) transgenic Drosophila but not similarly treated VRQ(cyt) flies (Thackray 500 
et al. submitted).  501 
 502 
A feature of the response by AHQ(cyt) transgenic Drosophila to atypical scrapie toxicity was 503 
the requirement for ubiquitous PrP expression in the fly. The lack of susceptibility of pan 504 
neuronal AHQ(cyt) but not VRQ(cyt) transgenic Drosophila to scrapie prions would not 505 
appear to be due to the level of ovine PrP expressed in these flies since cytosolic PrP was 506 
expressed at a similar level in both Elav-driven fly lines. Furthermore, resistance to atypical 507 
scrapie toxicity by Drosophila transgenic for pan neuronal expression of AHQ(cyt) did not 508 
appear to be due to the topological expression of PrP in this fly line since Drosophila 509 
transgenic for pan neuronal expression of AHQ(GPI) were also refractive to the same 510 
inocula. The need for ubiquitous PrP expression in AHQ PrP transgenic Drosophila for 511 
susceptibility to atypical scrapie toxicity may reflect a low infectious titre in these particular 512 
prion-infected isolates compared to classical scrapie material. Alternatively, atypical scrapie 513 
infectivity may be more unstable than its classical scrapie counterpart. It is known that the 514 
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PrPSc associated with atypical scrapie is less PK resistant compared to that associated with 515 
classical scrapie (56, 57). Whatever the case, ubiquitous expression of PrP in Drosophila 516 
may provide an environment for enhanced uptake and neuroinvasion of scrapie-infected 517 
material and generation of the toxic agent compared to pan neuronal expression, which may 518 
be more important for the response to atypical scrapie prion inocula. In mammalian species 519 
PrPC is ubiquitously expressed, a feature that plays an essential role in the transmission of 520 
prion infectivity in naturally acquired cases of prion disease (58), which may include atypical 521 
scrapie (41, 42). However, not all of the ovine PrP transgenic fly lines used here required 522 
ubiquitous expression of PrP in order to succumb to atypical scrapie prion inocula. 523 
Drosophila with pan neuronal expression of ovine ARQ(GPI) showed susceptibility to 524 
AHQ/AHQ atypical scrapie-infected sheep brain homogenate, as they do to ARQ/ARQ and 525 
VRQ/VRQ classical scrapie prion inocula (59). The promiscuous susceptibility of ARQ(GPI) 526 
PrP flies to atypical and classical scrapie-induced toxicity correlates with the high level of 527 
ovine prion protein expressed by this fly line (45). It is known that the transmission barrier 528 
effect (1) can be circumvented by elevated levels of PrP expression. For example, tg338 529 
mice that express high levels of ovine VRQ PrP are susceptible to atypical scrapie isolates 530 
whereas VRQ/VRQ sheep are resistant (34, 42). Collectively, these observations suggest 531 
that Drosophila engineered for elevated levels of ubiquitous cell surface or cytosolic PrP 532 
expression will be susceptible to a greater diversity of scrapie prion isolates and potentially 533 
lower quantities of associated toxicity. This suggests that PrP transgenic Drosophila could 534 
provide the basis of a new animal model to bioassay low levels of infectious toxicity in 535 
peripheral tissues and blood of prion-affected animals.  536 
 537 
Our studies with cytosolic PrP transgenic Drosophila presented here begin to contribute to an 538 
understanding of the potential role of topological variants in prion-induced neurotoxicity. 539 
While the mechanism of prion toxicity remains to be defined, it is established that PrP 540 
expression is required for susceptibility to the neurotoxic agent. The essential requirement for 541 
PrP expression in prion-induced neurotoxicity may suggest an intermediate in the conversion 542 
of PrPC to PrPSc is the neurotoxic agent (60, 61). An alternative possibility is that 543 
neurotoxicity results from PrPSc interference with the normal biosynthesis and metabolism of 544 
PrPC (25). PrP can accumulate in the cytosol in a misfolded form when proteasomal activity 545 
is compromised (28, 31) and cytosolic PrP has been reported to be neurotoxic in some 546 
neurons (26, 55). However, the neurotoxicity of cytosolic PrP per se has been debated (62, 547 
63). Our observations here have shown that while cytosolic PrP can adopt a conformation 548 
distinct from PrP targeted to the cell membrane, expression of PrP(cyt) in Drosophila does 549 
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not result in the accumulation of a transmissible toxic moiety without prior exposure of these 550 
flies to exogenous prion inocula. Collectively, our data presented here suggest that cytosolic 551 
PrP is not overtly toxic to neurons per se but may participate in a toxicity mediated by scrapie 552 
prion inocula, possibly by acting as a substrate for the generation of PrP-dependent 553 
transmissible moiety that initiates or maintains repression of neuronal proteostasis (29, 30, 554 
64-66). The tractable nature of Drosophila as a genetically and biochemically well-defined 555 
experimental model will allow us to test the validity of this hypothesis.  556 
 557 
 558 
 559 
 560 
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Legends 576 
 577 
Figure 1. Western blot detection of cytosolic ovine PrP expression in Drosophila  578 
Head homogenates were prepared from 5 day old ovine PrP transgenic Drosophila or 51D 579 
control flies crossed with the Elav-GAL4 driver fly line.  Samples were analyzed by SDS-580 
PAGE and western blot with anti-PrP monoclonal antibody Sha31. (a) Molecular profile of 581 
ARQ(cyt); AHQ(cyt); VRQ(cyt) all at the equivalent of 10 fly heads per track. Mature length 582 
ovine VRQ recombinant PrP (rPrP) was used at 10 ng. Molecular mass marker values (kDa) 583 
are shown on the left hand side. (b) Comparison of ovine PrP(cyt) and PrP(GPI) expression 584 
in Drosophila. Tracks 1 and 2: PrP(cyt); tracks 3 and 4: PrP(GPI); tracks 1 and 3; male flies; 585 
tracks 2 and 4; female flies. The equivalent of 5 fly heads were run per track. Molecular mass 586 
marker values (kDa) are shown on the left hand side.  The ovine PrP genotype is indicated 587 
on the right hand side. 588 
 589 
Figure 2. Capture-detector immunoassay analysis of cytosolic ovine PrP expression 590 
in Drosophila 591 
Head homogenates were prepared from 5 day old ovine PrP transgenic Drosophila or 51D 592 
control flies crossed with the Elav-GAL4 driver fly line.  Samples were analyzed by: (a) ELISA 593 
using anti-PrP monoclonal antibody 245 as capture and biotinylated anti-PrP monoclonal 594 
antibody SAF32 as detector. The equivalent of 10 fly heads were measured per well and the 595 
results shown are OD415nm means ± SD for duplicate wells; (b) Conformational-dependent 596 
immunoassay (CDI). Fly head homogenates were treated with 8M GdnHCl prior to 597 
immunoassay using anti-PrP monoclonal antibody 245 as capture and biotinylated anti-PrP 598 
monoclonal antibody SAF32 as detector. The equivalent of 20 fly heads were measured per 599 
well. Mature length ovine ARQ recombinant PrP (rPrP) was used at 122 ng/well. The results 600 
are shown as time resolved fluorescence (TRF) counts per second (cps) ± SD for duplicate 601 
wells. 602 
 603 
Figure 3. Cytosolic ovine PrP is characterized by reduced solubility and increased PK 604 
resistance  605 
Head homogenates were prepared from 5 day old ovine ARQ(cyt) or ARQ(GPI) PrP 606 
transgenic Drosophila crossed with the Elav-GAL4 driver fly line. After various treatments fly 607 
head homogenate samples were analyzed by SDS-PAGE and western blot with anti-PrP 608 
monoclonal antibody Sha31. The equivalent of 10 fly heads were loaded per track. Molecular 609 
mass marker values (kDa) are shown on the left hand side of each gel. (a) Total (T), soluble 610 
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(S) and insoluble (I) fractions of PrP were prepared from fly heads as described in the 611 
Materials and Methods. (b) Reaction products of fly head homogenates incubated with 612 
various concentrations of PK at 37 °C for 30 minutes.  613 
 614 
Figure 4. Survival curves for cytosolic ovine PrP transgenic Drosophila 615 
Groups of 100 age-matched Elav-PrP or control Elav-51D flies were selected for survival 616 
assays. The number of surviving flies was recorded three times a week as described in the 617 
Materials and Methods. Survival curves were calculated using Kaplan-Meier plots and 618 
differences between them were analyzed by the log-rank method using Prism (GraphPad 619 
Software Inc, San Diego, USA).  620 
 621 
Figure 5. Primary transmission of classical ovine scrapie in cytosolic VRQ PrP 622 
transgenic Drosophila 623 
VRQ(cyt) PrP transgenic (squares) or 51D control flies (circles) crossed with either the β-624 
actin-GAL4 or Elav-GAL4 driver line were assessed for locomotor activity by a negative 625 
geotaxis climbing assay following exposure at the larval stage to VRQ/VRQ scrapie-infected 626 
(filled symbols) or scrapie-free (open symbols and dashed lines) sheep brain homogenate. β-627 
actin-GAL4-VRQ(cyt) PrP flies were non RFP. The mean performance index ± SD is shown 628 
for three groups of n=15 flies of each genotype per time point (45 flies in total for each 629 
group). Statistical analysis of the linear regression plots was performed using one-way 630 
analysis of variance (ANOVA) and post hoc Tukey honestly significant difference. 631 
 632 
Figure 6. PK digestion of prion-exposed cytosolic VRQ fly head homogenate 633 
Fly head homogenates were prepared from ovine VRQ(cyt) PrP transgenic Drosophila 634 
crossed with the Elav-GAL4 driver fly line following exposure at the larval stage to VRQ/VRQ 635 
scrapie-free (tracks 1 - 3) or scrapie-infected (tracks 4 - 6) sheep brain homogenate. 636 
Samples were incubated with 0, 10 or 30 µg/ml PK at 37 ˚C for 15 minutes and the reaction 637 
products analyzed by SDS-PAGE and western blot with anti-PrP monoclonal antibody 638 
Sha31. The equivalent of 10 fly heads were loaded per track. Molecular mass marker values 639 
(kDa) are shown on the left hand side of each gel. Age of flies (in days) is shown on the right.  640 
 641 
Figure 7. Fly-to-fly transmission of prion-induced toxic phenotype  642 
VRQ(cyt) PrP (non RFP) transgenic flies crossed with the β-actin-GAL4 driver line were 643 
assessed for locomotor activity by a negative geotaxis climbing assay following exposure at 644 
the larval stage to a 10 % (v/v) dilution of head homogenate derived from 30 day old 645 
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Drosophila exposed at the larval stage to either scrapie-infected (filled squares) or scrapie-646 
free (open squares and dashed line) sheep brain homogenate. The mean performance index 647 
± SD is shown for three groups of n=15 flies of each genotype per time point (45 flies in total 648 
for each group). Statistical analysis of the linear regression plots was performed using one-649 
way analysis of variance (ANOVA) and post hoc Tukey honestly significant difference. 650 
 651 
Figure 8. Primary transmission of atypical scrapie in β-actin-driven PrP transgenic 652 
Drosophila 653 
PrP transgenic or 51D control flies crossed with the β-actin-GAL4 driver line were assessed 654 
for locomotor activity by a negative geotaxis climbing assay following exposure at the larval 655 
stage to AHQ/AHQ scrapie-infected (filled circles) or scrapie-free (open circles and dashed 656 
lines) sheep brain homogenate. The mean performance index ± SD is shown for three 657 
groups of n=15 flies of each genotype per time point (45 flies in total for each group). 658 
Statistical analysis of the scrapie-infected and scrapie-free linear regression plots for each fly 659 
line was compared by the unpaired samples t test.  660 
 661 
Figure 9. Lack of response by Elav-driven AHQ PrP transgenic Drosophila to atypical 662 
scrapie 663 
PrP transgenic or 51D control flies crossed with the Elav-GAL4 driver line were assessed for 664 
locomotor activity by a negative geotaxis climbing assay following exposure at the larval 665 
stage to AHQ/AHQ scrapie-infected (closed squares and continuous line) or scrapie-free 666 
(closed circles and dashed line) sheep brain homogenate or PBS (closed triangles and 667 
dotted line). The mean performance index ± SD is shown for three groups of n=15 flies of 668 
each genotype per time point (45 flies in total for each group). Statistical analysis of the linear 669 
regression plots was performed using one-way analysis of variance (ANOVA) and post hoc 670 
Tukey honestly significant difference. 671 
 672 
 673 
 674 
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Figure 1. Western blot detection of cytosolic ovine PrP expression in Drosophila!
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Figure 2. Capture-detector immunoassay analysis of cytosolic ovine PrP expression in Drosophila!
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Figure 3. Cytosolic ovine PrP is characterized by reduced solubility and increased PK resistance!
Figure 4. Survival curves for cytosolic ovine PrP transgenic Drosophila!
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Figure 5. Primary transmission of classical ovine scrapie in cytosolic VRQ PrP transgenic Drosophila!
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Figure 6. PK digestion of prion-exposed cytosolic VRQ fly head homogenate !
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Figure 7. Fly-to-fly transmission of prion-induced toxic phenotype!
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Figure 8. Primary transmission of atypical scrapie in β-actin-driven PrP transgenic Drosophila!
(a) β-actin-AHQ(cyt) ! (b) β-actin-AHQ(GPI) !
(c) β-actin-ARQ(GPI) ! (d) β-actin-51D !
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Figure 9: Lack of response by Elav-driven AHQ PrP transgenic Drosophila to atypical scrapie!
(a) Elav-AHQ(cyt) ! (b) Elav-AHQ(GPI) !
(c) Elav-ARQ(GPI) ! (d) Elav-51D !
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